Company Name
ARS Pharmaceuticals, Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US82835W1080
CIK:
0001671858
CUSIP:
82835W108
Currency:
USD
Full Time Employees:
162
Phone:
858 771 9307
Website:
https://ars-pharma.com
Fiscal Year End:
December
IPO Date:
Dec 04, 2020
Description:
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.
Address:
11682 El Camino Real, San Diego, CA, United States, 92130